Skip to main content
. 2020 Jul 22;7(8):1327–1339. doi: 10.1002/acn3.51121

Figure 5.

Figure 5

Changes in MG‐ADL mean domain scores from REGAIN baseline to OLE week 130 for (A) ocular, (B) bulbar, (C) respiratory, and (D) limb domains. Patient numbers were not the same for each assessment. Data are from patients with abnormal domain scores at REGAIN baseline only. BL = baseline; CI = confidence interval; MG‐ADL = myasthenia gravis activities of daily living profile; OLE = open‐label extension.